1[1]Parrott AC.Human psychopharmacology of ecstasy(MD-MA):a review of 15 years of empirical research[J].Human psychopharmacology:clin and exper,2001,16(8):557.
2[2]Shepherd MF,Lake KD,Kamps MA.Postmortem changes and pharmacokinetics:review of the literature and case report[J].Ann Pharmacother,1992,26(4):510-514.
3Grob S, Poland E. MDMA. In: Lowinson JH, Ruiz P, Millman RB, et al, eds. Substance abuse, 3rd Ed
4Steele TD,McCann UD,Ricaurte GA.3,4-methylenedioxy methamphetamine (MDMA,ECSTASY):Pharmacology and toxicology in animals and humans[J].Addiction,1994,89:539-551.
5Garbino J,Henry JA,Mentha G,et al.Ecstasy ingestion and fulminant hepatic failure:liver transplantation to be considered as a last therapeutic option[J].Vet-Hum-Toxicol,2001,43(2):99-102.
7L S Seiden,K E sabol.Methamphetamine and methylenedioxy methamphetamine neurotoxicity:possible mechanisms of cell destruction[J].NIDA Res Monogr 1996,163:251-276.
8Morton J. Ecstasy: Pharmacology and neurotoxicity[J]. Curt Opin Pharmacol, 2005,5, 79-86.
9NIDA Research Report - MDMA Abuse (Ecstasy):Printed April 2004.
10De La Torte R, Farre M, et al. Non-linear pharmacokinetics of MDMA("ecstasy" )in humans[J]. Br J ClinPharmacol, 2000, 49:104.
